Hepatocellular carcinoma (HCC) is a highly lethal cancer with limited treatment options and poor prognosis. Carbon ion radiotherapy (CIRT) has emerged as a promising treatment modality for HCC due to its unique physical and biological properties. CIRT uses carbon ions to target and destroy cancer cells with a high precision and efficacy. The Bragg Peak phenomenon allows precise dose delivery to the tumor while minimizing damage to healthy tissues. In addition, the high relative biological effectiveness of carbon ions can be shown against radioresistant and hypoxic tumor areas. CIRT also offers a shorter treatment schedule than conventional radiotherapy, which increases patient convenience and compliance. The clinical outcomes of CIRT for HCC have shown excellent local control rates with minimal side effects. Considering its physical and biological properties, CIRT may be a viable option for complex clinical scenarios such as patients with poor liver function, large tumors, re-irradiation cases, and tumors close to critical organs. Further research and larger studies are needed to establish definitive indications for CIRT and to compare its efficacy with that of other treatment modalities. Nevertheless, CIRT offers a potential breakthrough in HCC management, providing hope for improved therapeutic outcomes and reduced treatment-related toxicities.
Comparison of Prognostic Outcomes Between Repeat Liver Resection and Particle Therapy for Patients with Recurrent Hepatocellular Carcinoma Tatsuki Kusuhara, Hidetoshi Gon, Kazuki Terashima, Shohei Komatsu, Yoshiro Matsuo, Sunao Tokumaru, Hirochika Toyama, Masahiro Kido, Tomoaki Okimoto, Takumi Fukumoto Annals of Surgical Oncology.2025; 32(2): 1073. CrossRef
Tumor‐Targeted Catalytic Immunotherapy En‐Li Yang, Wu‐Yin Wang, Ying‐Qi Liu, Hong Yi, Aiwen Lei, Zhi‐Jun Sun Advanced Materials.2025;[Epub] CrossRef
Validation study on accuracy of our newly proposed methods for post-therapeutic liver reserve capacity estimation utilizing 99 mTc-GSA scintigraphy prior to carbon-ion radiotherapy Kana Yamazaki, Tatsuya Higashi, Ryuichi Nishii, Tamasa Terada, Yoichi Mizutani, Yuki Ogura, Mana Akamatsu, Toshitaka Kuroiwa, Hirokazu Makishima, Masaru Wakatsuki, Hitoshi Ishikawa Annals of Nuclear Medicine.2025; 39(8): 781. CrossRef
Study on the application of multislice spiral CT in the diagnosis and evaluation of radiotherapy efficacy for esophageal cancer W. Huang, L. Wang, H. Ye International Journal of Radiation Research.2025; 23(1): 121. CrossRef
Cost-Effectiveness of Carbon Ion Radiotherapy in Oncology: A Systematic Review Abdulrahman Bin Sumaida, Nandan M Shanbhag, Khalifa AlKaabi, Khalid Balaraj Cureus.2025;[Epub] CrossRef
First report of metabolic complete response in hepatic sarcomatoid carcinoma achieved with carbon-ion radiotherapy Ryu Takakura, Yoshiyuki Ota, Yuki Yamazaki, Satoru Iwamoto, Koki Kurouchi, Koki Moriyoshi, Shin’ichi Miyamoto Clinical Journal of Gastroenterology.2025; 18(5): 879. CrossRef
Advances in radiotherapy for mouth neoplasms: emerging technologies and future perspectives Xuhong Liu, Zhuoya Zhang, Xinyu Deng, Zekun Lang, Jianrong Wang Discover Oncology.2025;[Epub] CrossRef
Adverse Events After Carbon-Ion Radiotherapy (CIRT) for Hepatocellular Carcinoma and Risk Factors for Biliary Stricture After CIRT: A Retrospective Study Keita Maki, Hiroaki Haga, Tomohiro Katsumi, Kyoko Hoshikawa, Fumiya Suzuki, Fumi Uchiyama, Takashi Kaneko, Masashi Koto, Yoshiyuki Ueno Cancers.2025; 17(15): 2542. CrossRef
Treatment Outcomes in Patients Receiving Carbon-Ion Radiotherapy Versus Hepatectomy for Hepatocellular Carcinoma (≥4 cm): A Retrospective Study in Japan Keita Maki, Hiroaki Haga, Tomohiro Katsumi, Kyoko Hoshikawa, Takashi Kaneko, Ryosuke Takahashi, Shuichiro Sugawara, Masashi Koto, Fuyuhiko Motoi, Yoshiyuki Ueno Journal of Clinical Medicine.2025; 14(16): 5678. CrossRef
Carbon-Ion Radiotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects: A Narrative Review Reina Sasaki-Tanaka, Hiroyuki Abe, Tomoaki Yoshida, Yusuke Watanabe, Naruhiro Kimura, Takeshi Yokoo, Akira Sakamaki, Hiroteru Kamimura, Kenya Kamimura, Tatsuo Kanda, Shuji Terai Journal of Clinical Medicine.2025; 14(17): 6107. CrossRef
Carbon-ion radiotherapy induces ferroptosis and M1 macrophage polarization to inhibit the development of gastric cancer by downregulating DHODH Yue Wang, Hongyi Cai Frontiers in Medicine.2025;[Epub] CrossRef
A multi‐modal diffusion model for noise reduction of particle number limited Monte Carlo dose calculation for carbon ion radiotherapy Jueye Zhang, Youfang Lai, Haonan Feng, Xiangde Luo, Kai‐Wen Li, Tenghui Wang, Cheng Chang, Gen Yang, Chen Lin, Tian Li, Chao Yang, Yibao Zhang Medical Physics.2025;[Epub] CrossRef
Targeting gut microbiota and metabolites in cancer radiotherapy Shuling Ma, Xinpei Li, Shijie Shang, Zijun Zhai, Meng Wu, Qian Song, Dawei Chen Clinical and Translational Medicine.2025;[Epub] CrossRef
Potential applications of metal-based nanomaterials in tumor radiotherapy: from x-ray to particle therapies Yingxin Liu, Butuo Li, Linlin Wang Cancer Nanotechnology.2025;[Epub] CrossRef
The research perspectives and frontiers on radiotherapy for hepatocellular carcinoma: a bibliometric analysis and systematic review Tao He, Hong Xiao, Bin Yi, Chengyan Zhou, Juan Yang, Ke Sun, Jieyu Zou Frontiers in Oncology.2025;[Epub] CrossRef
Metronidazole-modified Au@BSA nanocomposites for dual sensitization of radiotherapy in solid tumors Qijun Du, Ho-Yin Yuen, Jingke Pan, Chenwei Sun, Di Wu, Jie Liu, Guohua Wu, Xin Zhao, Shuqi Wang Journal of Materials Chemistry B.2024; 12(38): 9686. CrossRef
Value of Carbon-Ion Radiation Therapy for Breast Cancer Bowen Yu, Kai-Wen Li, Yingyi Fan, Xiaohua Pei International Journal of Particle Therapy.2024; 14: 100629. CrossRef
Advances in external beam radiation for hepatocellular carcinoma, stereotactic body radiation therapy (SBRT) and particle therapy Lokesh Seth, Kevin L. Stephans Hepatoma Research.2024;[Epub] CrossRef
Mechanisms of Cancer Cell Radioresistance: Modern Trends and Research Prospects M. G Sharapov, E. E Karmanova, S. V Gudkov Biofizika.2024; 69(6): 1235. CrossRef
Mechanisms of Cancer Cell Radioresistance: Modern Trends and Research Prospects M. G. Sharapov, E. E. Karmanova, S. V. Gudkov Biophysics.2024; 69(6): 1064. CrossRef
Biological and clinical significance of radiomics features obtained from magnetic resonance imaging preceding pre-carbon ion radiotherapy in prostate cancer based on radiometabolomics Guangyuan Zhang, Zhenshan Zhang, Yulei Pei, Wei Hu, Yushan Xue, Renli Ning, Xiaomao Guo, Yun Sun, Qing Zhang Frontiers in Endocrinology.2023;[Epub] CrossRef
Novel paradigm in the treatment of hepatocellular carcinoma: Anticipating breakthroughs with particle therapy Sang Min Yoon Clinical and Molecular Hepatology.2023; 29(4): 977. CrossRef
Pencil Beam Scanning Carbon Ion Radiotherapy for Hepatocellular Carcinoma Wenna Zhang, Xin Cai, Jiayao Sun, Weiwei Wang, Jingfang Zhao, Qing Zhang, Guoliang Jiang, Zheng Wang Journal of Hepatocellular Carcinoma.2023; Volume 10: 2397. CrossRef
First
Prev
